President Trump wants to make a deal on drug prices. But his latest proposal could grind medical innovation to a halt.

Health and Human Services Secretary Alex Azar said last week that the president was looking for “most favored nation status,” whereby the United States got “the best deal among developed countries” for prescription drugs.